DLL3 and small cell lung carcinoma: The only significant result was shown with regard to age: DLL3-high SCLCs were more frequent in younger patients (median age 57 years) and SCLC with low DLL3 expression more frequent in older patients (median age 67) (p = 0.024) (Table 2).